| Ytd | 62.30% | |
| 1y | 47.68% |
| Open | 29.32 | Prev Close | 30.24 | Low | 28.55 | High | 30.22 | Mkt Cap | 2.17B |
| Vol | 5.23M | Avg Vol | 1.35M | EPS | -0.73 | P/E | N/A | Forward P/E | -21.50 |
| Beta | 1.69 | Short Ratio | 9.57 | Inst. Own | 96.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 18.19 | 200-d Avg | 15.30 | 1yr Est | 21.43 |
U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal.
Schrödinger, Inc. has undergone significant changes, including pipeline cuts and a strategic pivot a
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on September 13, 202
Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcr
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14,
Schrödinger, Inc. (NASDAQ:SDGR) today announced the formation of Tectora, a new biotechnology compan
NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Schrödinger announced the formation of Tectora, a biotech i
Jupiter Topco LLC bought a new stake in shares of Schrodinger, Inc. (NASDAQ: SDGR) during the second
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will par
BlackRock Inc. purchased a new position in Schrodinger, Inc. (NASDAQ: SDGR) during the undefined qua
RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing
On August 14, 2026, Schrodinger Inc (SDGR) shares fell 4.8% to $17.58, continuing a trend of volatil
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026, the company granted restri
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026,
Weave Communications (NYSE: WEAV - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report)
Anthropic is preparing what could be the largest IPO of 2026, and it's telling investors the pitch g
Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript
Schrodinger NASDAQ: SDGR said second-quarter annual contract value growth accelerated as demand broa
Schrodinger (NASDAQ: SDGR) said second-quarter annual contract value growth accelerated as demand br
Schrodinger, Inc. (SDGR) came out with quarterly earnings of $0.08 per share, beating the Zacks Cons
NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Today Schrödinger announced financial results for the quart
Schrödinger, Inc. (Nasdaq: SDGR) today announced the launch of its early access version of Bunsen, i
Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A de
Morgan Stanley analyst Vikram Malhorta maintains Schrodinger (NASDAQ:SDGR) with a Equal-Weight an
Schrodinger (NASDAQ:SDGR) affirms FY2026 sales outlook from $273.000 million-$293.000 million to $27
Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.63) per share which met the analyst conse
Keybanc analyst Brandon Nispel maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers t
UBS analyst Michael Yee maintains Schrodinger (NASDAQ:SDGR) with a Neutral and lowers the price t
Schrodinger (NASDAQ:SDGR) sees FY2026 sales of $273.000 million-$293.000 million vs $301.358 million
Schrodinger (NASDAQ:SDGR) reported quarterly sales of $87.200 million which beat the analyst consens
Schrödinger, Inc. (NASDAQ:SDGR) provided an update on its progress across the business in 2025 and a
TD Cowen analyst Brendan Smith maintains Schrodinger (NASDAQ:SDGR) with a Buy and lowers the pric
Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers
UBS analyst Michael Yee initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutral rating and
B of A Securities analyst Michael Ryskin upgrades Schrodinger (NASDAQ:SDGR) from Neutral to Buy a
Schrodinger (NASDAQ:SDGR) affirms FY2025 sales outlook from $243.440 million-$257.460 million to $24
Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.57) per share which beat the analyst cons
Copernic Catalysts, Inc. (Copernic) today announced that, in collaboration with Schrödinger, Inc. (N
Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers
Goldman Sachs analyst Andrea Newkirk initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutr
-SEC Filing-SEC Filing